Yahoo Finance10d
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
3 Amneal Naloxone HCI Nasal Spray is now available. According to IQVIA ®, U.S. annual commercial sales for NARCAN ® Naloxone HCl Nasal Spray 4mg for the 12 months ended February 2024 were $266 ...
The New York Times11d
Is Nasal Spray Addictive?
The resulting repeated need for nasal spray isn’t ... active ingredients like oxymetazoline (Afrin, Sinex) and phenylephrine (Neo-Synephrine), Dr. McCoul said. Decongestant sprays temporarily ...
Morningstar10d
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the availability of Over the Counter (“OTC”) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray ...
Yahoo Finance10d
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 24, 2024--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone ...
WebMD10d
Ipratropium nasal - Uses, Side Effects, and More
Nasal ipratropium is available in the following dosage forms that are sprayed into the nose. 21 mcg/spray as a 0.03% nasal solution 42 mcg/spray as a 0.06% nasal solution How should I store nasal ...
Monthly Prescribing Reference17d
Dristan 12-hr Nasal Spray
Oxymetazoline HCl 0.05%; contains benzalkonium chloride. <6yrs: not recommended. ≥6yrs: 2–3 sprays in each nostril not more than every 10–12hrs. Max 2 doses/24hrs for 3 days. Nasal ...
WebMD16d
Allergy Relief: Antihistamines vs. Decongestants
You get temporary relief, but your symptoms come back worse than before. So, if you use nasal decongestant sprays, limit it to a maximum of 3 days. If you decide to use one, be patient.
BioSpace10d
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the availability of Over the ...